Trending

COVID-19 Vaccine 90% Effective In Phase Three Trial, Says Pfizer

In a major breakthrough, US-based pharma company Pfizer Inc and German biotech company BioNTech announced that their mRNA-based COVID-19 vaccine candidate, BNT162b2, has demonstrated evidence of efficacy against the novel coronavirus in participants on November 9.The result was based on the first...